To Evaluate the Effect of Glibenclamide in Reducing Brain Edema of TBI
Clinical trial NCT05148403 · UNKNOWN
Trial details
- NCT number
- NCT05148403
- Sponsor
- Beijing Tiantan Hospital
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-22
- Primary completion
- 2022-10-01
- Enrollment
- 76
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.